Skip to main content
. 2017 Apr 26;8(28):45898–45917. doi: 10.18632/oncotarget.17438

Table 1A. Study population (N=39).

All pts pAKTS473 low pAKTS473 high pERK1/2T202/Y204 ≤ median pERK1/2T202/Y204 > median
pp70S6K1T389 < median 13 8 18 3
pp70S6K1T389 > median 6 12 3 15
p = 0.075, chi-square;odds ratio (95% CI): 3.250 (0.870-12.137) p < 0.0001, chi-square;odds ratio (95% CI): 30.000 (5.261-171.062)
pERK1/2T202/Y204 ≤ median 14 7
pERK1/2T202/Y204 > median 5 13
p = 0.015, chi-square;odds ratio (95% CI): 5.200 (1.317-20.539)